Unibest

Pharmaceutical intermediates

Gadobutrol Intermediates

1 pharmaceutical intermediate for Gadobutrol. Indication: Coronary artery disease; Aortic disease; Imaging examination; Breast disease; Vascular disease.

提交项目All intermediates

About Gadobutrol

Originator
Bayer Healthcare Pharmaceuticals Inc
Indication
Coronary artery disease; Aortic disease; Imaging examination; Breast disease; Vascular disease
Approved Date
03/14/2011

Available intermediates

1 intermediate currently listed for Gadobutrol. Request specifications, documentation or a quotation for any item below.

Gadobutrol intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Cyclen294-90-6//

Other programs under G

GepotidacinGilteritinib

Building toward Gadobutrol?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →